S&P 500: 662.29 -0.6% NASDAQ 100: 593.72 -0.6% Dow Jones: 466.41 -0.2%

Ray Dalio’s RKLB Holdings & Trades

First Buy
Q3 2025
Duration Held
2 Quarters
Largest Add
Q3 2025
+177,334 Shares
Current Position
43,496 Shares
$3.03 M Value

Ray Dalio's RKLB Position Overview

Ray Dalio (via Bridgewater Associates, Lp) currently holds 43,496 shares of Rocket Lab Corporation (RKLB) worth $3.03 M, representing 0.01% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.

Based on recent 13F filings, Ray Dalio has initiated a new position in RKLB, representing a fresh investment thesis on this company. Largest reduction occurred in Q4 2025, reducing 133,838 shares.

Analysis based on 13F filings available since 2013 Q2

Ray Dalio's Rocket Lab Corporation (RKLB) Holding Value Over Time

Track share changes against reported price movement

Quarterly Rocket Lab Corporation (RKLB) Trades by Ray Dalio

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 -133,838 Reduce 75.47% 43,496 $69.76
Q3 2025 +177,334 New Buy 177,334 $47.91

Ray Dalio's Rocket Lab Corporation Investment FAQs

Ray Dalio first purchased Rocket Lab Corporation (RKLB) in Q3 2025, acquiring 177,334 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ray Dalio has held Rocket Lab Corporation (RKLB) for 2 quarters since Q3 2025.

Ray Dalio's largest addition to Rocket Lab Corporation (RKLB) was in Q3 2025, adding 177,334 shares worth $8.5 M.

According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 43,496 shares of Rocket Lab Corporation (RKLB), valued at approximately $3.03 M.

As of the Q4 2025 filing, Rocket Lab Corporation (RKLB) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.

Ray Dalio's peak holding in Rocket Lab Corporation (RKLB) was 177,334 shares, as reported at the end of Q3 2025.